GeminIQ

EXAS

EXACT SCIENCES CORP
—

Company Information

Company Name
EXACT SCIENCES CORP
CIK
CIK0001124140
Category
Large accelerated filer
Ticker: Exchange
EXAS: Nasdaq
Fiscal Year End
December 31
Owner Organization
08 Industrial Applications and Services
SIC
8071
SIC Description
Services-Medical Laboratories
Ticker
EXAS

SEC filing data through

Insider Sentiment

Last purchase
2024-11-13
Last sale
2025-11-19
Shares purchased (TTM)
0
Shares sold (TTM)
30,550
Buy ratio (TTM)0.0%

Institutional Sentiment

As of
2026-03-31
Institutional shares owned
43,466
Shares outstanding
188,688,000
Ownership
0.02%
-90.82% Y/Y

Earnings Market Reaction

Filing date
2026-02-13
Price on filing date
—
1-month reaction
0.25%
3-month reaction
…
Drift continued8/11 (73%)
Faded / reversed3/11 (27%)
Export data

Balance Sheet

Values in millions ($)
Line item2025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-31Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash And Cash Equivalents At Carrying Value956789657347601589530347605595604421
Marketable Securities Current9214201439437432417305172140171277
Accounts Receivable Net Current299306353280249265264241204199178183
Inventory Net166165171177162137127129127133131124
Prepaid Expense And Other Assets Current1261171251281221101149986828985
Assets Current1,5561,5911,5081,3701,5711,5331,4521,1201,1941,1481,1741,091
Assets Noncurrent
Property Plant And Equipment Net709704705698694690703702698692687685
Operating Lease Right Of Use Asset122121126127117122140142144150149157
Goodwill2,3682,3682,3682,3672,3672,3672,3672,3672,3672,3672,3462,346
Intangible Assets Net Excluding Goodwill9209419659891,0101,8641,8431,8671,8901,9131,9111,933
Other Assets Noncurrent1861751251601701711671781771519092
Assets5,8615,9005,7975,7115,9286,7496,6736,3766,4716,4216,3566,304
Liabilities Current
Accounts Payable Current1761291571429098536079747587
Accrued Liabilities Current416409317295328314303265342310300242
Operating Lease Liability Current343231302727272729303030
Other Liabilities Current15141635383637331513349
Convertible Notes Payable Current00002492492492490---
Liabilities Current641584522502732724669685515477488367
Liabilities Noncurrent
Convertible Long Term Notes Payable2,3272,3262,3242,3232,3212,3192,3182,0672,3142,3132,3122,310
Long Term Loans Payable--------00050
Other Liabilities Noncurrent329325316320316332327329336342331344
Operating Lease Liability Noncurrent162164166169157163168162161168169175
Liabilities3,4603,3993,3283,3143,5263,5383,4813,2443,3263,3003,2993,247
Stockholders Equity
Preferred Stock Value000000000000
Common Stock Value222222222222
Additional Paid In Capital Common Stock7,1037,1167,0656,9936,8996,8376,7876,7116,6116,5406,4766,397
Accumulated Other Comprehensive Income Loss Net Of Tax2331-15-1-01-2-1-2
Retained Earnings Accumulated Deficit-4,706-4,620-4,600-4,599-4,498-3,633-3,595-3,579-3,469-3,419-3,420-3,339
Stockholders Equity2,4012,5012,4692,3972,4023,2113,1923,1333,1453,1213,0573,058
Liabilities And Stockholders Equity5,8615,9005,7975,7115,9286,7496,6736,3766,4716,4216,3566,304
Loans Payable Current----00050505050-
Preferred Stock Par Or Stated Value Per Share0.010.010.010.010.010.010.010.010.010.010.010.01
Preferred Stock Shares Authorized555555555555
Preferred Stock Shares Issued000000000000
Preferred Stock Shares Outstanding000000000000
Common Stock Par Or Stated Value Per Share0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized400400400400400400400400400400400400
Common Stock Shares Issued191189189189186185185184181181181180
Shares Outstanding191189189189186185185184181181181180

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

EXACT SCIENCES CORP (EXAS) — SEC Financial Statements & Analysis

EXACT SCIENCES CORP (EXAS) is a services-medical laboratories company. EXACT SCIENCES CORP trades on Nasdaq as: EXAS. EXACT SCIENCES CORP (EXAS)'s most recent SEC filing is a Form 10-K for the period ended 2025-12-31, filed with the SEC on 2026-02-13. Based on its latest SEC filing (Form 10-Q, period ending 2025-12-31), On profitability, EXACT SCIENCES CORP posts a gross margin of 265.98%, an operating margin of -24.25%, a net margin of -24.44%, a Return on Equity (ROE) of -8.66%, a Return on Assets (ROA) of -3.53%, and a Return on Invested Capital (ROIC) of -4.95%. Per share, it reports EPS of $-1.10, diluted EPS of $-1.10, free cash flow per share of $1.89, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 20.05% year-over-year, net income growth of -79.79% year-over-year, and EPS growth of -80.27% year-over-year. On the balance sheet, it maintains a current ratio of 2.43x, a quick ratio of 1.97x, working capital of $914.70M, a debt-to-equity ratio of 1.44x, a debt ratio of 0.59, an interest coverage ratio of -5.24x, free cash flow of $356.78M (TTM), and net debt of $1.37B. Figures sourced from SEC EDGAR.

EPS TTM
$-1.10
ROE TTM
-8.66%
ROA TTM
-3.53%
Debt To Equity
1.44x
Free Cash Flow TTM
$356.78M
Net Revenue TTM Growth 1Y
20.05%

Data as of 2025-12-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is EXACT SCIENCES CORP in?

EXACT SCIENCES CORP (EXAS) operates in the Services-Medical Laboratories industry.

What exchange does EXAS trade on?

EXACT SCIENCES CORP (EXAS) trades on the Nasdaq.

When was EXACT SCIENCES CORP (EXAS)'s most recent SEC filing?

EXACT SCIENCES CORP (EXAS)'s most recent SEC filing is a Form 10-K for the period ended 2025-12-31, filed with the SEC on 2026-02-13.

What is EXAS's EPS (earnings per share)?

EXACT SCIENCES CORP (EXAS)'s trailing twelve month EPS is $-1.10 as of 2025-12-31.

What is EXAS's ROE (return on equity)?

EXACT SCIENCES CORP (EXAS)'s trailing twelve month Return on Equity (ROE) is -8.66% as of 2025-12-31.

What is EXAS's ROA (return on assets)?

EXACT SCIENCES CORP (EXAS)'s trailing twelve month Return on Assets (ROA) is -3.53% as of 2025-12-31.

What is EXAS's ROIC (return on invested capital)?

EXACT SCIENCES CORP (EXAS)'s trailing twelve month Return on Invested Capital (ROIC) is -4.95% as of 2025-12-31.

Wall Street's data.
Main Street's price.

Start 7-day free trial